References
- DrenthJPMichielsJJErythromelalgia and erythermalgia: diagnostic differentiationInt J Dermatol19943363933978056469
- YangYWangYLiSMutations in SCN9A, encoding a sodium channel alpha subunit, in patients with primary erythermalgiaJ Med Genet200441317117414985375
- DavisMDO’FallonWMRogersRS3rdRookeTWNatural history of erythromelalgia: presentation and outcome in 168 patientsArch Dermatol2000136333033610724194
- EmeryECLuizAWoodJNNav1.7 and other voltage-gated sodium channels as drug targets for pain reliefExpert Opin Ther Targets20162081926420565
- de MosMde BruijnAGHuygenFJDielemanJPStrickerBHSturkenboomMCThe incidence of complex regional pain syndrome: a population-based studyPain20071291–2122017084977
- HardenNBruehlSPerezRSValidation of proposed diagnostic criteria (the ‘Budapest Criteria’) for Complex Regional Pain SyndromePain2010150226827420493633
- CaoLMcDonnellANitzscheAPharmacological reversal of a pain phenotype in iPSC-derived sensory neurons and patients with inherited erythromelalgiaSci Transl Med20168335335ra56
- WaxmanSMerkiesISGerritsMMSodium channel genes in pain-related disorders: phenotype–genotype associations and recommendations for clinical useLancet Neurol201413111152116025316021
- EstacionMHanCChoiJSIntra- and interfamily phenotypic diversity in pain syndromes associated with a gain-of-function variant of NaV1.7Mol Pain201179222136189
- ChoiJSZhangLDib-HajjSDMexiletine-responsive erythromelalgia due to a new Nav1.7 mutation showing use-dependent current fall-offExp Neurol2009216238338919162012
- FischerTZGilmoreESEstacionMA novel Nav1.7 mutation producing carbamazepine-responsive erythromelalgiaAnn Neurol200965673374119557861
- GehaPYangYEstacionMPharmacotherapy for pain in a family with inherited erythromelalgia guided by genomic analysis and functional profilingJAMA Neurol201673665966727088781
- ZhangZSchmelzMSegerdahlMExonic mutations in SCN9A (NaV1.7) are found in a minority of patients with erythromelalgiaScand J Pain201454217225
- SheetsMFFozzardHALipkindGMHanckDASodium channel molecular conformations and antiarrhythmic drug affinityTrends Cardiovasc Med2010201162120685573
- LipkindGMFozzardHAMolecular model of anticonvulsant drug binding to the voltage-gated sodium channel inner poreMol Pharmacol201078463163820643904
- Dib-HajjSYangYBlackJAWaxmanSGThe Na(V)1.7 sodium channel: from molecule to manNat Rev Neurosci2012141496223232607
- SchwartzmanRJAlexanderGMGrothusenJRPaylorTReichenbergerEPerreaultMOutpatient intravenous ketamine for the treatment of complex regional pain syndrome: a double-blind placebo controlled studyPain20091471–310711519783371
- WoolfCJThompsonSWThe induction and maintenance of central sensitization is dependent on N-methyl-D-aspartic acid receptor activation; implications for the treatment of post-injury pain hypersensitivity statesPain19914432932991828878